Search
for
Sort by
Research 31–60 of 99
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- COVID‐19, androgens, and androgenic alopecia
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Síndrome Pós-Covid-19: Manejo nutricional das principais alterações
- Dermatological Manifestations of COVID-19: A Brief Review
- Syndromes of Severe Insulin Resistance (SSIRs)
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- S2608 A Rare Case of Iron Deficiency Anemia: Cronkhite-Canada Syndrome
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Rare and common manifestations of COVID‐19 in children
- Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
- Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- A narrative review of SARS-CoV-2 variants and long COVID
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- ZALCITABINE